Neurocrine files for follow-on

NBIX filed to sell 3.3 million shares in a follow-on through Deutsche Banc Alex. Brown; CS First Boston; CIBC World Markets; Lehman; and UBS Warburg. NBIX, which is developing compounds for neurologic...